Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.15 trillion and total revenue of $110.17 billion.
Market Cap
1.15T
Revenue
110.17B
Profits
-40.04B
PE Ratio
n/a
Profit Margin
-36.34%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.45B | -1.11% | 1,127,921 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.13B | -1.89% | 809,391 | 14.34B |
| 3 | ARGX | argenx SE | 48.50B | -0.98% | 339,092 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.52B | -2.63% | 825,556 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.36B | 0.33% | 160,887 | 5.34B |
| 6 | RPRX | Royalty Pharma plc | 29.27B | -0.52% | 1,981,554 | 2.38B |
| 7 | INSM | Insmed Incorporated | 29.18B | -6.02% | 2,500,870 | 606.42M |
| 8 | RVMD | Revolution Medicines, Inc. | 28.46B | 0.61% | 3,501,174 | - |
| 9 | BNTX | BioNTech SE | 26.67B | -0.09% | 543,764 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 20.12B | -4.01% | 4,552,280 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 19.62B | -2.59% | 5,616,021 | 13.31M |
| 12 | INCY | Incyte Corporation | 18.84B | -0.86% | 1,116,994 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.14B | -0.85% | 5,253,890 | - |
| 14 | GMAB | Genmab A/S | 16.46B | -0.41% | 1,091,461 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.21B | 2.25% | 4,134,483 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.16B | 1.90% | 622,753 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.10B | -1.11% | 1,817,359 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.10B | -1.72% | 733,680 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.75B | -1.22% | 205,550 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.42B | -2.41% | 2,342,860 | 2.32B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.35B | -0.66% | 1,638,706 | 1.09B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.23B | -1.48% | 1,123,213 | 3.22B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.60B | 4.62% | 345,883 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.51B | 1.77% | 527,047 | 638.50M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.90B | 1.38% | 889,607 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.56B | -2.11% | 899,885 | - |
| 27 | TECH | Bio-Techne Corporation | 8.48B | 3.80% | 1,983,763 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.22B | -3.26% | 993,434 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.12B | -0.24% | 967,119 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 8.02B | 1.67% | 264,108 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.74B | -1.85% | 1,399,577 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.68B | -9.16% | 16,939,761 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.93B | -2.59% | 393,667 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | -0.02% | 2,215,345 | 22.29M |
| 35 | ERAS | Erasca, Inc. | 6.68B | -4.36% | 5,750,690 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -2.55% | 778,706 | 46.02M |
| 37 | BLTE | Belite Bio, Inc | 6.34B | -1.94% | 90,608 | - |
| 38 | APGE | Apogee Therapeutics, Inc. | 6.32B | -3.04% | 537,660 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.11% | 3,220,920 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.10B | 0.09% | 2,019,828 | 15.00M |
| 41 | SYRE | Spyre Therapeutics, Inc. | 6.01B | 0.62% | 600,990 | - |
| 42 | COGT | Cogent Biosciences, Inc. | 5.93B | 1.85% | 1,139,398 | - |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.85B | 0.58% | 310,208 | 189.76M |
| 44 | CELC | Celcuity Inc. | 5.85B | 6.58% | 1,070,889 | - |
| 45 | IMVT | Immunovant, Inc. | 5.82B | -1.14% | 1,359,492 | - |
| 46 | CGON | CG Oncology, Inc. | 5.80B | -1.73% | 507,020 | 4.04M |
| 47 | CAI | Caris Life Sciences, Inc. | 5.71B | 2.07% | 830,351 | 812.03M |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.66B | -0.52% | 640,428 | 1.73B |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | -0.50% | 442,381 | 521.31M |
| 50 | TGTX | TG Therapeutics, Inc. | 5.41B | -0.81% | 1,365,141 | 616.29M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.34B | -2.11% | 1,294,644 | - |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.27B | -0.31% | 601,370 | 7.50M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 2,079,640 | 1.00B |
| 54 | CORT | Corcept Therapeutics Incorporated | 4.94B | 2.17% | 632,562 | 761.41M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -2.71% | 349,226 | 2.04M |
| 56 | CRSP | CRISPR Therapeutics AG | 4.70B | -11.59% | 3,851,211 | 3.51M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | 1.22% | 171,346 | 268.09M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.21% | 5,285,334 | 634.21M |
| 59 | LEGN | Legend Biotech Corporation | 4.42B | -0.38% | 1,369,154 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.01B | -0.47% | 1,053,280 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.80B | -0.15% | 2,037,455 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -0.68% | 868,122 | 1.07B |
| 63 | TVTX | Travere Therapeutics, Inc. | 3.74B | -0.78% | 1,363,138 | 490.73M |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.72B | -0.39% | 5,157,794 | 62.38M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.61B | 3.63% | 177,593 | 803.79M |
| 66 | ORKA | Oruka Therapeutics, Inc. | 3.47B | 1.90% | 1,091,939 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.42B | -5.53% | 1,003,004 | 22.50M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.39B | 1.12% | 1,033,864 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.34B | -1.12% | 1,970,156 | 588.99M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.22B | -3.25% | 835,418 | - |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.20B | 1.47% | 731,360 | 247.00M |
| 72 | ALMS | Alumis Inc. | 3.17B | -4.08% | 1,248,339 | 24.05M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.15B | 2.16% | 1,174,210 | - |
| 74 | NKTR | Nektar Therapeutics | 3.09B | 0.46% | 922,217 | 55.23M |
| 75 | DYN | Dyne Therapeutics, Inc. | 3.02B | -3.39% | 1,234,923 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | 1.75% | 1,090,581 | 376.07M |
| 77 | RLAY | Relay Therapeutics, Inc. | 2.86B | 0.27% | 1,968,383 | 15.36M |
| 78 | KLRA | Kailera Therapeutics, Inc. | 2.78B | -10.41% | 1,209,729 | - |
| 79 | KOD | Kodiak Sciences Inc. | 2.77B | -0.82% | 433,995 | - |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.73B | -0.21% | 3,281,966 | 190.41M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.72B | -10.11% | 4,713,753 | 139.74M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.70B | -1.82% | 1,721,950 | - |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | 0.10% | 648,984 | 218.71M |
| 84 | IMNM | Immunome, Inc. | 2.67B | 2.48% | 590,168 | 6.94M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.65B | 0.82% | 667,164 | - |
| 86 | IRON | Disc Medicine, Inc. | 2.63B | 0.78% | 317,359 | - |
| 87 | ADMA | ADMA Biologics, Inc. | 2.62B | 1.62% | 4,221,148 | 510.17M |
| 88 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 0.79% | 723,237 | 451.36M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.61B | -0.77% | 597,018 | 1.55M |
| 90 | ZLAB | Zai Lab Limited | 2.56B | 4.07% | 497,977 | 460.16M |
| 91 | MANE | Veradermics, Incorporated | 2.53B | -2.04% | 345,126 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -0.74% | 1,538,142 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -3.44% | 603,753 | - |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.24B | -3.35% | 2,621,508 | - |
| 95 | TYRA | Tyra Biosciences, Inc. | 2.24B | 2.45% | 1,051,320 | - |
| 96 | AAPG | Ascentage Pharma Group International | 2.20B | 7.21% | 7,239 | 82.08M |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 2.32% | 876,072 | 276.98M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | -0.59% | 2,076,721 | 2.20B |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.99% | 1,275,171 | 283.06M |
| 100 | ZYME | Zymeworks Inc. | 2.07B | 2.44% | 570,590 | 105.97M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -1.04% | 2,643,200 | 51.95M |
| 102 | CAPR | Capricor Therapeutics, Inc. | 2.04B | 4.16% | 964,532 | 11.13M |
| 103 | MESO | Mesoblast Limited | 2.03B | 0.13% | 87,771 | 65.38M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 1.55% | 970,254 | - |
| 105 | STOK | Stoke Therapeutics, Inc. | 2.01B | -2.58% | 398,234 | 184.42M |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | 1.86% | 1,694,107 | 172.35M |
| 107 | INBX | Inhibrx Biosciences, Inc. | 1.89B | 7.61% | 617,153 | 1.30M |
| 108 | GLPG | Galapagos NV | 1.88B | -0.14% | 102,891 | 1.31B |
| 109 | PHVS | Pharvaris N.V. | 1.87B | 4.73% | 156,026 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 0.29% | 9,350,983 | 74.68M |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | - | 1,928,014 | 9.77M |
| 112 | VCEL | Vericel Corporation | 1.82B | 3.60% | 565,694 | 276.26M |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -3.99% | 933,298 | 868.45M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.77B | -2.72% | 115,645 | - |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 0.55% | 230,307 | - |
| 116 | INVA | Innoviva, Inc. | 1.75B | 0.38% | 456,589 | 411.33M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 0.66% | 575,695 | 71.78M |
| 118 | SION | Sionna Therapeutics, Inc. | 1.71B | -0.63% | 518,006 | - |
| 119 | NUVB | Nuvation Bio Inc. | 1.70B | -2.98% | 4,236,081 | 62.90M |
| 120 | ANAB | AnaptysBio, Inc. | 1.69B | 14.84% | 1,335,620 | 234.60M |
| 121 | ATAI | AtaiBeckley Inc. | 1.69B | -2.94% | 5,977,325 | 4.09M |
| 122 | VIR | Vir Biotechnology, Inc. | 1.67B | 0.19% | 1,262,537 | 68.56M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.63B | -0.47% | 279,524 | 31.89M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.61B | -14.11% | 9,028,287 | 67.67M |
| 125 | NBTX | Nanobiotix S.A. | 1.60B | -0.39% | 58,340 | 38.27M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -1.88% | 575,186 | 123.67M |
| 127 | OCS | Oculis Holding AG | 1.56B | -1.23% | 310,591 | 1.51M |
| 128 | IMTX | Immatics N.V. | 1.52B | 1.79% | 246,696 | 56.67M |
| 129 | MBX | MBX Biosciences, Inc. | 1.52B | -4.28% | 448,128 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.49B | -2.64% | 166,705 | - |
| 131 | IMCR | Immunocore Holdings plc | 1.49B | 0.24% | 229,591 | 400.02M |
| 132 | BHVN | Biohaven Ltd. | 1.49B | -6.08% | 1,694,545 | - |
| 133 | AGIO | Agios Pharmaceuticals, Inc. | 1.48B | -1.63% | 972,390 | 54.03M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.48B | -0.83% | 359,366 | - |
| 135 | PGEN | Precigen, Inc. | 1.46B | 4.29% | 3,459,179 | 9.68M |
| 136 | ARDX | Ardelyx, Inc. | 1.46B | -0.17% | 2,254,429 | 407.32M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.43B | -0.77% | 503,984 | 2.50M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | -1.15% | 11,715,211 | 263.50M |
| 139 | VRDN | Viridian Therapeutics, Inc. | 1.42B | -3.51% | 1,052,646 | 70.85M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.38B | -1.78% | 2,800,894 | 42.73M |
| 141 | OLMA | Olema Pharmaceuticals, Inc. | 1.35B | 1.17% | 661,335 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 0.37% | 1,269,851 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -1.87% | 877,571 | - |
| 144 | NVAX | Novavax, Inc. | 1.34B | 0.86% | 1,788,624 | 1.12B |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.31B | 2.23% | 530,955 | - |
| 146 | SVRA | Savara Inc. | 1.30B | 3.64% | 929,627 | - |
| 147 | ABCL | AbCellera Biologics Inc. | 1.26B | 2.47% | 9,417,136 | 75.13M |
| 148 | GHRS | GH Research PLC | 1.26B | 7.66% | 277,332 | - |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.23B | 1.48% | 672,313 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.23B | -0.91% | 766,639 | - |
| 151 | DBVT | DBV Technologies S.A. | 1.18B | 2.33% | 152,877 | 5.64M |
| 152 | AKTS | Aktis Oncology, Inc. | 1.18B | -3.71% | 267,411 | 6.50M |
| 153 | PHAR | Pharming Group N.V. | 1.17B | 0.24% | 6,311 | 376.13M |
| 154 | URGN | UroGen Pharma Ltd. | 1.17B | -0.82% | 585,357 | 109.79M |
| 155 | EYPT | EyePoint, Inc. | 1.15B | -0.51% | 625,638 | 31.37M |
| 156 | QURE | uniQure N.V. | 1.14B | 2.79% | 1,005,006 | 16.10M |
| 157 | SEPN | Septerna, Inc. | 1.11B | -1.20% | 595,429 | 45.95M |
| 158 | ZBIO | Zenas BioPharma, Inc. | 1.08B | -1.62% | 564,707 | 10.00M |
| 159 | IVA | Inventiva S.A. | 1.06B | -0.81% | 297,650 | 7.94M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 1.68% | 1,063,664 | 291.85M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -1.82% | 1,071,913 | - |
| 162 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | 2.88% | 978,676 | 73.62M |
| 163 | OMER | Omeros Corporation | 974.11M | 0.07% | 1,523,828 | - |
| 164 | GERN | Geron Corporation | 961.35M | - | 12,919,826 | 183.88M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 957.85M | -1.12% | 2,422,912 | 76.20M |
| 166 | ANNX | Annexon, Inc. | 955.54M | -2.97% | 1,393,813 | - |
| 167 | XNCR | Xencor, Inc. | 951.94M | 4.26% | 627,218 | 125.58M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 929.33M | -3.78% | 1,485,267 | 175.11M |
| 169 | FTRE | Fortrea Holdings Inc. | 916.30M | 1.77% | 774,119 | 2.72B |
| 170 | EVMN | Evommune, Inc. | 914.15M | -1.78% | 259,584 | 13.00M |
| 171 | JANX | Janux Therapeutics, Inc. | 913.08M | -1.18% | 551,728 | 10.00M |
| 172 | MRVI | Maravai LifeSciences Holdings, Inc. | 912.59M | 2.90% | 1,032,053 | 185.74M |
| 173 | CMPX | Compass Therapeutics, Inc. | 905.84M | -3.45% | 5,058,845 | 850.00K |
| 174 | SANA | Sana Biotechnology, Inc. | 902.69M | -4.36% | 2,721,944 | - |
| 175 | LBRX | LB Pharmaceuticals Inc | 881.20M | -0.03% | 192,040 | - |
| 176 | DRUG | Bright Minds Biosciences Inc. | 872.11M | 0.54% | 126,170 | - |
| 177 | ANRO | Alto Neuroscience, Inc. | 859.49M | -4.63% | 195,017 | - |
| 178 | MGTX | MeiraGTx Holdings plc | 854.30M | -0.97% | 673,398 | 81.39M |
| 179 | TBPH | Theravance Biopharma, Inc. | 847.57M | 0.92% | 277,354 | 107.46M |
| 180 | MNKD | MannKind Corporation | 833.75M | -0.37% | 2,776,174 | 348.97M |
| 181 | ABUS | Arbutus Biopharma Corporation | 827.15M | -1.18% | 8,003,994 | 14.08M |
| 182 | CBIO | Crescent Biopharma, Inc. | 823.70M | -3.42% | 258,528 | 10.84M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 823.17M | -0.12% | 2,059,051 | 84.28M |
| 184 | KURA | Kura Oncology, Inc. | 821.94M | -0.11% | 852,928 | 67.48M |
| 185 | SLS | SELLAS Life Sciences Group, Inc. | 800.94M | -3.88% | 7,225,725 | - |
| 186 | CGEM | Cullinan Therapeutics, Inc. | 800.16M | 2.08% | 638,806 | - |
| 187 | ALLO | Allogene Therapeutics, Inc. | 794.59M | -1.70% | 5,527,351 | 22.00K |
| 188 | SGP | SpyGlass Pharma, Inc. | 786.19M | -0.47% | 91,539 | - |
| 189 | SLDB | Solid Biosciences Inc. | 779.29M | -3.65% | 736,981 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 772.75M | -1.96% | 413,178 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 756.24M | -0.55% | 681,137 | - |
| 192 | VOR | Vor Biopharma Inc. | 748.30M | -5.54% | 1,075,416 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 719.30M | 2.36% | 366,217 | - |
| 194 | DRTS | Alpha Tau Medical Ltd. | 712.00M | 1.38% | 285,491 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | - | 1,931,965 | 49.80M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 702.69M | -2.12% | 385,146 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 679.38M | - | 32,192 | 116.59M |
| 198 | FBRX | Forte Biosciences, Inc. | 671.93M | -4.89% | 189,000 | - |
| 199 | ARVN | Arvinas, Inc. | 667.75M | 0.19% | 635,130 | 262.60M |
| 200 | PRME | Prime Medicine, Inc. | 655.19M | -3.65% | 1,593,855 | 4.63M |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 631.04M | -4.42% | 762,697 | - |
| 202 | ABSI | Absci Corporation | 602.90M | -0.76% | 4,391,472 | 2.80M |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 597.68M | -5.49% | 1,508,191 | 7.83M |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 595.88M | -0.30% | 708,308 | 106.47M |
| 205 | ANL | Adlai Nortye Ltd. | 592.00M | -0.74% | 322,214 | 5.00M |
| 206 | PROK | ProKidney Corp. | 585.80M | -3.00% | 703,136 | 893.00K |
| 207 | STTK | Shattuck Labs, Inc. | 585.00M | 1.18% | 231,921 | 1.00M |
| 208 | CRMD | CorMedix Inc. | 581.94M | 1.23% | 656,966 | 311.71M |
| 209 | PRTA | Prothena Corporation plc | 578.70M | 0.19% | 287,824 | 9.68M |
| 210 | OCGN | Ocugen, Inc. | 561.94M | -0.60% | 6,141,384 | 4.41M |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 559.76M | -1.40% | 306,286 | 294.28M |
| 212 | ALT | Altimmune, Inc. | 553.47M | -1.38% | 14,733,746 | 41.00K |
| 213 | STRO | Sutro Biopharma, Inc. | 552.19M | -4.31% | 344,351 | 102.48M |
| 214 | KYTX | Kyverna Therapeutics, Inc. | 548.40M | 1.23% | 1,489,115 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 538.54M | 3.27% | 59,615 | - |
| 216 | TECX | Tectonic Therapeutic, Inc. | 535.88M | 0.35% | 255,779 | - |
| 217 | ENGN | enGene Therapeutics Inc. | 535.25M | -1.84% | 222,225 | - |
| 218 | LYEL | Lyell Immunopharma, Inc. | 522.79M | -5.04% | 53,469 | 36.00K |
| 219 | EIKN | Eikon Therapeutics, Inc. | 522.71M | -9.77% | 176,849 | - |
| 220 | IMMX | Immix Biopharma, Inc. | 522.17M | -3.15% | 385,231 | - |
| 221 | FULC | Fulcrum Therapeutics, Inc. | 522.15M | -2.97% | 839,113 | 80.00M |
| 222 | VSTM | Verastem, Inc. | 519.15M | -5.14% | 1,692,805 | 30.91M |
| 223 | ZURA | Zura Bio Limited | 510.46M | -2.54% | 642,677 | - |
| 224 | MDXG | MiMedx Group, Inc. | 509.58M | 2.39% | 1,691,922 | 418.63M |
| 225 | UPB | Upstream Bio, Inc. | 506.11M | -3.02% | 558,812 | 2.85M |
| 226 | ADCT | ADC Therapeutics SA | 501.13M | -0.51% | 933,906 | 81.36M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 479.88M | -2.19% | 514,601 | 85.21M |
| 228 | CADL | Candel Therapeutics, Inc. | 476.11M | -7.67% | 1,691,672 | - |
| 229 | ARMP | Armata Pharmaceuticals, Inc. | 473.30M | -4.51% | 53,365 | 4.90M |
| 230 | PRLD | Prelude Therapeutics Incorporated | 472.60M | 6.82% | 865,216 | 12.14M |
| 231 | LRMR | Larimar Therapeutics, Inc. | 471.63M | 0.89% | 1,107,232 | - |
| 232 | VALN | Valneva SE | 470.89M | 3.19% | 148,804 | 205.07M |
| 233 | AURA | Aura Biosciences, Inc. | 466.73M | 0.14% | 299,510 | - |
| 234 | CTNM | Contineum Therapeutics, Inc. | 463.34M | -0.08% | 138,397 | - |
| 235 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.09M | 2.21% | 517,461 | 170.16M |
| 236 | TRDA | Entrada Therapeutics, Inc. | 454.68M | -1.41% | 161,013 | 25.42M |
| 237 | RGNX | REGENXBIO Inc. | 452.17M | -2.56% | 756,829 | 170.44M |
| 238 | XOMA | XOMA Royalty Corporation | 451.61M | -0.08% | 89,647 | 52.15M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.11M | -1.24% | 167,710 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 442.09M | -1.62% | 56,974 | 72.30M |
| 241 | CLYM | Climb Bio, Inc. | 436.60M | 1.33% | 260,932 | - |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 435.81M | -0.91% | 209,912 | - |
| 243 | LXEO | Lexeo Therapeutics, Inc. | 433.41M | -2.66% | 940,450 | - |
| 244 | BNTC | Benitec Biopharma Inc. | 423.73M | -2.60% | 140,920 | - |
| 245 | NGNE | Neurogene Inc. | 422.09M | 0.30% | 273,080 | 925.00K |
| 246 | IVVD | Invivyd, Inc. | 412.89M | -3.31% | 1,412,141 | 53.43M |
| 247 | NMRA | Neumora Therapeutics, Inc. | 411.05M | 0.90% | 854,707 | - |
| 248 | VNDA | Vanda Pharmaceuticals Inc. | 407.25M | 2.99% | 1,037,092 | 216.11M |
| 249 | VTVT | vTv Therapeutics Inc. | 406.54M | -6.00% | 129,104 | 17.00K |
| 250 | PRTC | PureTech Health plc | 402.93M | -4.56% | 7,046 | 6.39M |
| 251 | IPSC | Century Therapeutics, Inc. | 399.73M | -1.77% | 768,389 | 109.16M |
| 252 | NAGE | Niagen Bioscience, Inc. | 395.62M | 4.23% | 489,355 | 129.42M |
| 253 | IMRX | Immuneering Corporation | 390.77M | -1.47% | 748,021 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 386.25M | -0.30% | 164,733 | 66.98M |
| 255 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | -0.64% | 818,529 | 14.56M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 384.11M | -4.35% | 1,877,202 | - |
| 257 | YDES | YD Bio Limited | 383.95M | 4.00% | 5,760 | 510.36K |
| 258 | PBYI | Puma Biotechnology, Inc. | 383.61M | 1.89% | 195,644 | 228.37M |
| 259 | AUTL | Autolus Therapeutics plc | 383.25M | -5.88% | 1,371,529 | 75.39M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 373.68M | -3.97% | 527,020 | 35.11M |
| 261 | IRD | Opus Genetics, Inc. | 373.43M | 0.38% | 655,388 | 14.20M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 371.86M | -5.63% | 741,933 | 59.00K |
| 263 | SLN | Silence Therapeutics plc | 363.70M | -1.79% | 737,392 | 559.00K |
| 264 | MNPR | Monopar Therapeutics Inc. | 356.02M | -0.08% | 152,089 | - |
| 265 | PALI | Palisade Bio, Inc. | 348.24M | -4.15% | 4,689,128 | - |
| 266 | OVID | Ovid Therapeutics Inc. | 342.87M | -2.99% | 1,122,092 | 7.25M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 341.08M | 1.53% | 129,058 | - |
| 268 | BCYC | Bicycle Therapeutics plc | 337.38M | -0.21% | 401,858 | 72.59M |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 335.42M | 2.28% | 90,281 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 331.60M | 1.55% | 286,523 | - |
| 271 | CABA | Cabaletta Bio, Inc. | 328.40M | -3.28% | 1,983,274 | - |
| 272 | SRZN | Surrozen, Inc. | 323.24M | -8.16% | 111,009 | 3.48M |
| 273 | RZLT | Rezolute, Inc. | 322.00M | -0.32% | 1,321,619 | - |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 320.45M | -2.59% | 630,648 | 1.00 |
| 275 | NGEN | NervGen Pharma Corp. | 317.25M | -0.25% | 116,415 | - |
| 276 | FHTX | Foghorn Therapeutics Inc. | 311.70M | 2.31% | 81,062 | 30.91M |
| 277 | AVXL | Anavex Life Sciences Corp. | 309.52M | 0.91% | 617,523 | - |
| 278 | ABEO | Abeona Therapeutics Inc. | 306.60M | -2.36% | 928,596 | 5.82M |
| 279 | LENZ | LENZ Therapeutics, Inc. | 294.10M | 2.51% | 656,047 | 19.09M |
| 280 | CGEN | Compugen Ltd. | 293.12M | 6.16% | 1,248,437 | 72.76M |
| 281 | NERV | Minerva Neurosciences, Inc. | 288.26M | -3.73% | 188,072 | - |
| 282 | EDIT | Editas Medicine, Inc. | 284.81M | -9.35% | 1,513,828 | 40.52M |
| 283 | NBP | NovaBridge Biosciences | 283.34M | -0.81% | 358,486 | - |
| 284 | ZNTL | Zentalis Pharmaceuticals, Inc. | 282.31M | 2.31% | 1,031,626 | 26.87M |
| 285 | ACIU | AC Immune SA | 281.73M | -4.38% | 144,539 | 4.51M |
| 286 | CCCC | C4 Therapeutics, Inc. | 281.03M | -3.03% | 2,142,815 | 35.95M |
| 287 | CLLS | Cellectis S.A. | 280.95M | - | 11,207 | 79.59M |
| 288 | HELP | Cybin Inc. | 280.70M | -2.43% | 1,920,636 | - |
| 289 | TARA | Protara Therapeutics, Inc. | 277.45M | -2.47% | 405,482 | - |
| 290 | CHRS | Coherus Oncology, Inc. | 269.88M | -0.57% | 906,190 | 42.17M |
| 291 | ALEC | Alector, Inc. | 265.97M | -0.82% | 320,542 | 21.05M |
| 292 | ELDN | Eledon Pharmaceuticals, Inc. | 263.22M | -3.48% | 1,678,123 | - |
| 293 | ARTV | Artiva Biotherapeutics, Inc. | 255.08M | -8.67% | 153,173 | 251.00K |
| 294 | SABS | SAB Biotherapeutics, Inc. | 247.37M | -7.37% | 555,970 | 114.70K |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 244.62M | 3.55% | 36,589 | 19.39M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 244.15M | 1.42% | 266,330 | 82.03M |
| 297 | ADAG | Adagene Inc. | 243.81M | -1.34% | 101,032 | 7.67M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 241.69M | -0.48% | 252,412 | 33.48M |
| 299 | CDXS | Codexis, Inc. | 238.08M | 3.97% | 1,745,201 | 70.39M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 235.81M | 2.70% | 108,302 | 44.64M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 235.78M | 1.25% | 72,057 | - |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 231.81M | 1.07% | 732,600 | 1.55M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 230.52M | - | 85,684 | 3.50M |
| 304 | PLYX | Polaryx Therapeutics, Inc. | 229.61M | -8.83% | 89,306 | - |
| 305 | KROS | Keros Therapeutics, Inc. | 226.95M | -0.43% | 256,595 | 244.06M |
| 306 | VYGR | Voyager Therapeutics, Inc. | 225.88M | -6.19% | 583,456 | 40.37M |
| 307 | ALXO | ALX Oncology Holdings Inc. | 224.72M | 5.03% | 858,864 | - |
| 308 | HRTX | Heron Therapeutics, Inc. | 224.48M | 19.02% | 6,080,717 | 154.90M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 215.05M | -1.35% | 74,920 | - |
| 310 | MDWD | MediWound Ltd. | 214.89M | 0.42% | 52,387 | 16.96M |
| 311 | ACHV | Achieve Life Sciences, Inc. | 214.02M | -3.13% | 791,751 | - |
| 312 | OABI | OmniAb, Inc. | 211.38M | -6.41% | 463,276 | 18.67M |
| 313 | ENLV | Enlivex Ltd. | 210.91M | -2.01% | 256,827 | - |
| 314 | NKTX | Nkarta, Inc. | 208.17M | -2.01% | 781,673 | - |
| 315 | CNTX | Context Therapeutics Inc. | 207.65M | -2.59% | 2,506,369 | - |
| 316 | CRBU | Caribou Biosciences, Inc. | 205.84M | -5.75% | 1,915,156 | 11.16M |
| 317 | MGNX | MacroGenics, Inc. | 202.76M | 0.31% | 589,316 | 149.50M |
| 318 | REPL | Replimune Group, Inc. | 199.83M | -15.09% | 8,854,153 | - |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 195.23M | -1.03% | 267,905 | 146.07M |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 193.20M | 1.19% | 285,135 | - |
| 321 | SGMT | Sagimet Biosciences Inc. | 190.95M | -0.17% | 252,133 | - |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 190.20M | -3.36% | 134,383 | 7.15M |
| 323 | KRRO | Korro Bio, Inc. | 185.91M | -5.22% | 100,223 | 6.39M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 185.59M | -3.75% | 495,599 | - |
| 325 | UNCY | Unicycive Therapeutics, Inc. | 183.98M | -0.82% | 270,346 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 181.65M | -3.69% | 209,905 | 34.26M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.13M | 0.96% | 276,182 | 13.11M |
| 328 | RNAC | Cartesian Therapeutics, Inc. | 178.94M | -3.16% | 118,867 | 2.80M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 178.43M | -1.57% | 242,835 | - |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 175.65M | 1.87% | 407,159 | 52.74M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 170.15M | -4.19% | 1,017,593 | 70.00M |
| 332 | MENS | Jyong Biotech Ltd. | 168.41M | -3.52% | 61,501 | - |
| 333 | TLSA | Tiziana Life Sciences Ltd | 164.63M | 4.88% | 161,663 | - |
| 334 | PRQR | ProQR Therapeutics N.V. | 163.31M | -4.91% | 1,157,366 | 19.19M |
| 335 | SPRO | Spero Therapeutics, Inc. | 158.62M | -2.14% | 346,529 | 66.80M |
| 336 | ANTX | AN2 Therapeutics, Inc. | 156.22M | 1.87% | 236,581 | - |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 155.72M | 0.26% | 60,025 | 2.00M |
| 338 | MOLN | Molecular Partners AG | 155.64M | 1.36% | 1,086 | 856.30K |
| 339 | HUMA | Humacyte, Inc. | 155.41M | -1.14% | 2,241,514 | 2.04M |
| 340 | FATE | Fate Therapeutics, Inc. | 154.63M | 0.76% | 954,902 | 6.65M |
| 341 | GALT | Galectin Therapeutics Inc. | 153.38M | -1.69% | 180,517 | - |
| 342 | ALPS | Alps Group Inc | 149.76M | -1.64% | 3,911 | 3.74M |
| 343 | AGEN | Agenus Inc. | 149.75M | 3.72% | 770,294 | 114.20M |
| 344 | HURA | TuHURA Biosciences, Inc. | 149.41M | 2.62% | 944,507 | - |
| 345 | ACOG | Alpha Cognition Inc. | 149.26M | 0.07% | 19,838 | 10.22M |
| 346 | SPRB | Spruce Biosciences, Inc. | 146.92M | 0.67% | 59,395 | 697.00K |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 145.87M | -1.71% | 3,229,980 | - |
| 348 | CNTB | Connect Biopharma Holdings Limited | 142.43M | - | 151,479 | 64.00K |
| 349 | KZIA | Kazia Therapeutics Limited | 140.09M | 3.72% | 225,708 | 1.27M |
| 350 | KLRS | Kalaris Therapeutics, Inc. | 140.09M | 0.16% | 26,444 | - |
| 351 | BMEA | Biomea Fusion, Inc. | 136.65M | 1.07% | 1,249,480 | - |
| 352 | EQ | Equillium, Inc. | 136.57M | -0.46% | 523,035 | 4.39M |
| 353 | KALA | KALA BIO, Inc. | 126.50M | -11.62% | 7,360,344 | - |
| 354 | IPHA | Innate Pharma S.A. | 123.03M | 2.92% | 26,674 | 10.57M |
| 355 | VRCA | Verrica Pharmaceuticals Inc. | 119.91M | 7.55% | 112,664 | 35.58M |
| 356 | ONCY | Oncolytics Biotech Inc. | 119.61M | -5.50% | 925,510 | - |
| 357 | PYXS | Pyxis Oncology, Inc. | 119.38M | 11.11% | 726,665 | 13.86M |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 119.08M | -0.21% | 148,919 | 39.99K |
| 359 | AARD | Aardvark Therapeutics, Inc. | 117.59M | 0.37% | 115,528 | - |
| 360 | CRDF | Cardiff Oncology, Inc. | 117.59M | 2.99% | 412,025 | 593.00K |
| 361 | IMUX | Immunic, Inc. | 114.82M | -4.16% | 3,893,467 | - |
| 362 | CBUS | Cibus, Inc. | 114.42M | 3.45% | 396,790 | 3.64M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 114.37M | 1.59% | 694,165 | - |
| 364 | VANI | Vivani Medical, Inc. | 114.27M | 3.05% | 250,901 | - |
| 365 | GNLX | Genelux Corporation | 111.82M | - | 129,489 | 8.00K |
| 366 | SEER | Seer, Inc. | 111.15M | 1.55% | 1,148,072 | 16.58M |
| 367 | IFRX | InflaRx N.V. | 106.99M | -5.13% | 1,170,067 | 34.44K |
| 368 | PEPG | PepGen Inc. | 106.44M | -3.14% | 581,304 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 105.60M | 5.82% | 15,974 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 102.26M | 0.33% | 62,374 | - |
| 371 | COEP | Coeptis Therapeutics Holdings, Inc. | 102.06M | 1.17% | 111,929 | 1.36M |
| 372 | COYA | Coya Therapeutics, Inc. | 101.34M | -0.46% | 109,532 | 7.95M |
| 373 | PMN | ProMIS Neurosciences, Inc. | 100.80M | 3.31% | 31,360 | - |
| 374 | GUTS | Fractyl Health, Inc. | 98.36M | 6.71% | 2,605,380 | 3.00K |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 97.12M | 3.52% | 473,447 | 1.23M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 94.23M | 0.88% | 721,014 | 65.34K |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 93.71M | 2.56% | 486,834 | 1.63M |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 93.28M | -3.13% | 1,481,748 | - |
| 379 | QTTB | Q32 Bio Inc. | 91.00M | -4.01% | 264,847 | 53.74M |
| 380 | PYPD | PolyPid Ltd. | 88.16M | -0.43% | 43,708 | - |
| 381 | NRXS | NeurAxis, Inc. | 87.93M | 5.50% | 530,574 | 3.57M |
| 382 | EXOZ | eXoZymes, Inc. | 87.42M | -1.81% | 484 | -700.00 |
| 383 | GOSS | Gossamer Bio, Inc. | 85.12M | -2.92% | 3,262,454 | 48.47M |
| 384 | ACET | Adicet Bio, Inc. | 84.92M | - | 50,201 | - |
| 385 | OKYO | OKYO Pharma Limited | 84.49M | 1.26% | 31,070 | - |
| 386 | GANX | Gain Therapeutics, Inc. | 83.22M | 4.23% | 664,701 | - |
| 387 | CSBR | Champions Oncology, Inc. | 81.45M | -2.90% | 1,521 | 57.95M |
| 388 | SGMO | Sangamo Therapeutics, Inc. | 78.75M | -25.45% | 31,127,799 | 39.55M |
| 389 | LONA | LeonaBio, Inc. | 78.25M | -3.36% | 51,244 | - |
| 390 | FLNA | Filana Therapeutics, Inc. | 77.78M | -3.01% | 350,274 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 77.66M | 0.92% | 8,319 | 4.43M |
| 392 | MCRB | Seres Therapeutics, Inc. | 77.65M | 0.12% | 60,754 | 789.00K |
| 393 | PTHS | Pelthos Therapeutics Inc. | 77.38M | -0.60% | 14,654 | 16.80M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 77.05M | 0.79% | 458,738 | - |
| 395 | ATYR | aTyr Pharma, Inc. | 76.98M | -0.83% | 910,096 | 190.00K |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 76.79M | 0.70% | 337,024 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 76.77M | -1.59% | 339,036 | - |
| 398 | XBIT | XBiotech Inc. | 76.52M | -0.79% | 15,902 | - |
| 399 | TCRX | TScan Therapeutics, Inc. | 75.73M | 5.00% | 1,076,618 | 10.33M |
| 400 | ICCC | ImmuCell Corporation | 75.59M | 4.44% | 29,600 | 27.64M |
| 401 | FBIO | Fortress Biotech, Inc. | 75.03M | 4.48% | 194,721 | 63.26M |
| 402 | OSTX | OS Therapies Incorporated | 74.41M | 22.07% | 3,419,512 | - |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 74.00M | 1.06% | 413,694 | - |
| 404 | IMMP | Immutep Limited | 73.66M | 0.37% | 1,887,925 | 5.28M |
| 405 | ACTU | Actuate Therapeutics, Inc. | 70.42M | 17.39% | 283,361 | - |
| 406 | IBO | Impact BioMedical Inc. | 70.36M | -0.37% | 31,813 | 32.00K |
| 407 | BYSI | BeyondSpring Inc. | 70.11M | 2.71% | 2,998 | 1.88M |
| 408 | MNOV | MediciNova, Inc. | 67.43M | - | 19,404 | 409.66K |
| 409 | ESLA | Estrella Immunopharma, Inc. | 67.41M | -7.60% | 96,774 | - |
| 410 | OKUR | OnKure Therapeutics, Inc. | 65.63M | -2.04% | 73,135 | - |
| 411 | EDSA | Edesa Biotech, Inc. | 64.51M | 7.08% | 77,920 | - |
| 412 | IMA | ImageneBio, Inc. | 63.87M | -2.56% | 239,256 | 800.00K |
| 413 | CING | Cingulate Inc. | 63.61M | -2.67% | 414,241 | - |
| 414 | IBIO | iBio, Inc. | 60.72M | -7.18% | 1,161,356 | 300.00K |
| 415 | HYFT | MindWalk Holdings Corp. | 60.59M | 1.67% | 165,760 | 20.70M |
| 416 | ANVS | Annovis Bio, Inc. | 60.09M | -3.87% | 872,069 | - |
| 417 | CUE | Cue Biopharma, Inc. | 57.60M | 6.40% | 302,648 | 27.47M |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 56.43M | 4.90% | 136,718 | 25.21M |
| 419 | TIL | Instil Bio, Inc. | 54.63M | -1.53% | 23,678 | - |
| 420 | INKT | MiNK Therapeutics, Inc. | 54.38M | 2.05% | 34,741 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 54.15M | 0.83% | 35,128 | - |
| 422 | ENTX | Entera Bio Ltd. | 52.22M | -4.27% | 73,054 | 42.00K |
| 423 | RADX | Radiopharm Theranostics Limited | 50.62M | -0.33% | 17,666 | 10.86M |
| 424 | PDSB | PDS Biotechnology Corporation | 50.26M | -2.97% | 921,474 | - |
| 425 | ATOS | Atossa Therapeutics, Inc. | 49.08M | -0.52% | 42,677 | - |
| 426 | NTRB | Nutriband Inc. | 48.57M | -0.36% | 3,687 | 2.28M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | 1.45% | 59,204 | - |
| 428 | XLO | Xilio Therapeutics, Inc. | 48.05M | -1.89% | 33,146 | 43.77M |
| 429 | HYPD | Hyperion DeFi, Inc. | 47.50M | 6.11% | 228,287 | 813.46K |
| 430 | RNTX | Rein Therapeutics Inc. | 46.54M | -9.78% | 127,007 | - |
| 431 | MREO | Mereo BioPharma Group plc | 46.29M | -5.41% | 1,560,328 | 500.00K |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 46.09M | -1.43% | 151,901 | - |
| 433 | RLYB | Rallybio Corporation | 45.65M | 1.53% | 32,534 | 858.00K |
| 434 | PSTV | Plus Therapeutics, Inc. | 45.29M | -9.34% | 231,271 | 5.21M |
| 435 | LIXT | Lixte Biotechnology Holdings, Inc. | 43.10M | -6.78% | 52,012 | - |
| 436 | LITS | Lite Strategy, Inc. | 42.91M | - | 397,805 | - |
| 437 | SNSE | Sensei Biotherapeutics, Inc. | 42.61M | -2.54% | 6,063 | - |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 40.97M | 2.24% | 26,580 | 120.77M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 39.91M | -2.29% | 177,190 | 90.00K |
| 440 | ALGS | Aligos Therapeutics, Inc. | 39.60M | 4.40% | 161,996 | 2.19M |
| 441 | HOWL | Werewolf Therapeutics, Inc. | 39.51M | -5.48% | 175,284 | 1.14M |
| 442 | RNXT | RenovoRx, Inc. | 38.59M | -4.82% | 315,220 | 1.12M |
| 443 | NXTC | NextCure, Inc. | 37.46M | -15.16% | 137,275 | - |
| 444 | VERU | Veru Inc. | 37.24M | 0.43% | 19,429 | 16.89M |
| 445 | INMB | INmune Bio Inc. | 36.95M | 0.72% | 140,256 | 50.00K |
| 446 | CRVO | CervoMed Inc. | 35.92M | 0.78% | 31,410 | 4.01M |
| 447 | GRCE | Grace Therapeutics, Inc. | 35.59M | -2.13% | 3,319,337 | - |
| 448 | PTN | Palatin Technologies, Inc. | 35.53M | 8.13% | 5,425 | 8.96M |
| 449 | SKYE | Skye Bioscience, Inc. | 34.07M | 7.92% | 173,031 | - |
| 450 | SNTI | Senti Biosciences, Inc. | 33.95M | 7.92% | 207,013 | 22.00K |
| 451 | PLUR | Pluri Inc. | 33.62M | -2.76% | 9,240 | 1.34M |
| 452 | EVAX | Evaxion A/S | 33.61M | -5.18% | 31,460 | 7.53M |
| 453 | BOLD | Boundless Bio, Inc. | 33.61M | -1.32% | 123,740 | - |
| 454 | IGC | IGC Pharma, Inc. | 33.31M | -0.74% | 420,147 | 1.11M |
| 455 | OTLK | Outlook Therapeutics, Inc. | 32.96M | 9.83% | 4,091,113 | 205.70K |
| 456 | CELU | Celularity Inc. | 32.01M | -0.89% | 30,245 | 40.58M |
| 457 | TVGN | Tevogen Bio Holdings Inc. | 31.44M | 7.70% | 11,263 | - |
| 458 | DYAI | Dyadic International, Inc. | 31.34M | -0.69% | 22,461 | 3.09M |
| 459 | DARE | Daré Bioscience, Inc. | 30.72M | -0.47% | 333,390 | 1.03M |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 29.08M | 2.99% | 22,199 | - |
| 461 | LSTA | Lisata Therapeutics, Inc. | 28.90M | -3.90% | 32,513 | 170.00K |
| 462 | KYNB | Kyntra Bio, Inc. | 28.89M | 1.85% | 10,107 | 6.44M |
| 463 | APLM | Apollomics, Inc. | 28.52M | 0.32% | 1,608 | 8.99M |
| 464 | BCTX | BriaCell Therapeutics Corp. | 28.09M | 4.02% | 188,831 | - |
| 465 | PLRZ | Polyrizon Ltd. | 27.74M | 5.21% | 63,971 | - |
| 466 | LTRN | Lantern Pharma Inc. | 27.57M | 6.49% | 236,772 | - |
| 467 | LGVN | Longeveron Inc. | 27.52M | -3.73% | 171,343 | 1.20M |
| 468 | NNVC | NanoViricides, Inc. | 27.21M | -3.08% | 179,501 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 27.17M | 2.65% | 30,072 | 14.99M |
| 470 | AEON | AEON Biopharma, Inc. | 26.57M | 0.96% | 35,891 | - |
| 471 | NRSN | NeuroSense Therapeutics Ltd. | 26.52M | 4.92% | 207,674 | - |
| 472 | ABVC | ABVC BioPharma, Inc. | 26.44M | -6.14% | 114,149 | 797.92K |
| 473 | BRNS | Barinthus Biotherapeutics plc | 26.22M | 0.47% | 7,679 | 14.97M |
| 474 | CVM | CEL-SCI Corporation | 25.90M | -3.32% | 72,080 | - |
| 475 | TPST | Tempest Therapeutics, Inc. | 25.68M | -0.56% | 99,589 | - |
| 476 | SER | Serina Therapeutics, Inc. | 24.26M | 1.55% | 46,184 | 130.00K |
| 477 | CRIS | Curis, Inc. | 23.79M | -2.15% | 666,644 | 9.44M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.53M | 4.19% | 502,095 | 789.00K |
| 479 | JSPR | Jasper Therapeutics, Inc. | 23.47M | -7.37% | 625,317 | - |
| 480 | LEXX | Lexaria Bioscience Corp. | 23.39M | 0.10% | 84,345 | 368.00K |
| 481 | MRKR | Marker Therapeutics, Inc. | 23.34M | -3.45% | 78,016 | 3.55M |
| 482 | OSRH | OSR Holdings, Inc. | 22.96M | 16.43% | 2,001,859 | 2.91M |
| 483 | QNCX | Quince Therapeutics, Inc. | 22.17M | - | 1,178,924 | - |
| 484 | XCUR | Exicure, Inc. | 22.12M | -4.67% | 19,831 | 500.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.50M | 0.77% | 76,810 | 570.00K |
| 486 | NCEL | NewcelX Ltd. | 21.24M | -5.09% | 121,617 | - |
| 487 | ALLR | Allarity Therapeutics, Inc. | 21.20M | -4.29% | 91,996 | 320.00K |
| 488 | QNTM | Quantum BioPharma Ltd. | 21.09M | 12.46% | 248,698 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.71M | 1.42% | 141,339 | - |
| 490 | PASG | Passage Bio, Inc. | 18.73M | -1.02% | 56,357 | - |
| 491 | PBM | Psyence Biomedical Ltd. | 18.14M | -12.40% | 1,385,260 | - |
| 492 | LPCN | Lipocine Inc. | 17.67M | 2.98% | 139,936 | 1.98M |
| 493 | TOVX | Theriva Biologics, Inc. | 17.49M | - | 7,041,707 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 17.23M | -17.47% | 3,033,001 | 3.94M |
| 495 | KTTA | Pasithea Therapeutics Corp. | 17.21M | 0.10% | 194,607 | - |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 16.93M | -0.54% | 32,564 | - |
| 497 | GNTA | Genenta Science S.p.A. | 16.71M | 0.90% | 44,486 | - |
| 498 | ICU | SeaStar Medical Holding Corporation | 16.49M | -2.59% | 133,938 | 1.23M |
| 499 | HIND | Vyome Holdings, Inc. | 15.51M | -2.21% | 36,695 | 319.71K |
| 500 | HOTH | Hoth Therapeutics, Inc. | 15.49M | 1.52% | 481,932 | - |